by our clinical partners
More and more conditions are treated with proton therapy
As the number of proton therapy centers in operation grows, the amount of clinical data on proton therapy is increasing rapidly. Taking advantage of the day-to-day involvement with experienced clinical partners, IBA launched the initiative to gather and share information on the use of proton therapy in oncology. For some indications we have published white papers, for others there is a collection of recent research available in our bibliography on proton therapy research.
Please note that IBA is a cancer diagnostics and treatment equipment company and cannot advise on specific clinical conditions.
Discover the full list of white papers related to cancers treated with proton therapy
The use of conventional irradiation techniques can be accompanied by adverse effects that are highly undesirable, particularly in the case of a growing body. Irradiation with protons could prevent damage to important developing organs and preserve their function.
Skull-base and spine
Tumors in the base of the skull are frequently difficult to treat due to their close proximity to structures such as the brainstem, brain, cranial nerves and optic nerves. Surgical removal can be difficult and the dose of radiation that can be delivered with standard X-ray radiation treatments can be restricted. For more information about base of skull and spine cancers treated by our clinical partners read our white paper.
The treatment of ocular melanoma was one of the earliest uses of proton therapy. Since 1994, proton therapy has been regularly used in the United States to treat ocular cancers. The reason is that proton therapy is very effective in achieving local control of the melanoma without adversely affecting the survival rates. Find out more information on our clinical partners' treatment of ocular melanoma.
There are many different options available to treat lung cancer. Proton therapy is one of the most revolutionary methods of treatment, especially for stage III non-small cell lung cancer (NSCLC). Want more information about lung cancers treated by our clinical partners paper?
For prostate cancer, the aim is to increase rates of disease control while largely sparing adjacent normal tissue and critical organs such as rectum and bladder to achieve a low rate of radiation-related side effects. For more information about the genitourinary cancers treated by our clinical partners:
Treatment of GI tumors often requires a combination of radiation therapy and either chemotherapy or surgery. In some cases, standard radiation therapy isn’t a viable treatment option because it would cause too much damage to healthy tissues. For these patients, proton therapy can be an effective treatment option. For more information about the gastro-intestinal cancers treated by our clinical partners:
According to the American Cancer Society, every year more than 200,000 women are diagnosed with breast cancer. The main risk of conventional breast radiotherapy is unwanted radiation exposure of the heart, lungs and other organs. For more information about breast cancers treated by our clinical partners:
Hodgkin and Non-Hodgkin Lymphoma
Every year about 9,000 Americans are diagnosed with Hodgkin lymphoma and more than 65,000 with Non-Hodgkin lymphoma. Using proton therapy treatment instead of conventional radiation therapy enables a lower integral dose, which in turn lowers the risk of secondary cancers and cardiac toxicities, the primary causes of death for Hodgkin lymphoma survivors. For more information about the Hodgkin and Non-Hodgkin cancers treated by our clinical partners:
Central Nervous System
Unlike X-rays, protons precisely target a tumor and do not pass beyond it into healthy brain tissue. For this reason, patients experience fewer side effects with proton therapy than with standard radiation therapy. For more information about the central nervous system cancers treated by our clinical partners:
Sarcoma (large / retroperitoneal / extremities)
The nature of bone and soft tissue sarcomas makes them ideal candidates for treatment with proton therapy. Sarcoma tumors are often located near sensitive tissues and require high curative doses,so it is important to treat them with the most precise type of radiation available - proton therapy. For more information about the sarcoma cancers treated by our clinical partners:
Only a minority of patients are treatable after a recurrence of their cancer because the normal tissues cannot tolerate significant doses of additional radiation. Because protons spare normal tissues, many patients that were not previously retreatable with X-rays may be retreated with protons. This factor may result in the further increase of cure rates of some malignancies. For more information about reirradiation treatment performed by our clinical partners: